【2 月 20 日,港 A 股小幅回调,生物医药板块盘初拉升】消息称,《2025 年稳外资行动方案》提出完善医药领域开放政策,便利创新药上市等,歌礼制药小分子口服 GLP-1R 激动剂 ASC30 美国 Ib 期多剂量递增研究前两个队列有积极期中结果。AI+医疗催化下,连跌三年多的医疗板块春节后表现佳,医药生物年内上涨 3.75%,港股创新药类 ETF 近 5 日净流入 18.65 亿元。民生证券...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.